Anti-Candida Albicans HSP91 Homolog Recombinant Antibody

Name: Anti-Candida Albicans HSP91 Homolog Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1109

YR1109

科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab

DATASHEET MSDS

Product Description

Alias	科研级 Efungumab ( 依芬古单抗 ), Anti-HSP91 Homolog Recombinant Antibody, Research Grade Efungumab
Catalog Number	YR1109
Molecular Name	Efungumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	scFv-heavy Kappa
Formulation	PBS, pH7.5
Background	Efungumab (trade name Mycograb) was a drug developed by NeuTec Pharma (a subsidiary of Novartis), intended to treat candidemia (a bloodstream infection caused by pathogenic yeast) in combination with amphotericin B. The European Medicines Agency has twice refused to grant marketing authorization for Mycograb, citing product safety and quality issues.
CAS Number	762260-74-2
Application	FCM, IP, ELISA, Neut, FuncS, IF, WB
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	HSP91 homolog[Candida albicans]

Login